Leukemia Fusion Genes (Q30) Screening Kit
Product TypeAssay Kit
TechnologyqPCR
Regulatory StatusCE-IVD
Sample TypesWhole Blood
Key takeaways
Leukemia Fusion Genes (Q30) Screening Kit is a product in the Molecular Assays category, manufactured by Zeesan Biotech (致善生物). Listed regulatory status: CE-IVD (as reported by the manufacturer).
- Platform: qPCR
- Sample types: whole blood

Classification
- Category
- Molecular Assays
- Product Type
- Assay Kit
- Technology
- qPCR
Workflow
- Sample Types
- Whole Blood
Regulatory Status
CE-IVD
Reported from manufacturer sources and not independently verified.
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
Leukemia Fusion Genes (Q30) Screening Kit is a multiplex RT-qPCR based assay for detection of leukemia associated fusion gene transcripts in total RNA from bone marrow or whole blood samples.
The kit detects RNA transcripts of fusion genes extracted from human bone marrow or whole blood samples using a RT-qPCR procedure .
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-17
2026-10-31
availability varies
